advisorsecurities master

NBPNovaBridge Biosciences American Depositary Shares

ADRCNasdaq (XNAS)·USD

Identity

Security key
19028
Ticker
NBP
Type
ADRCAmerican Depository Receipt Common
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2020-01-17
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
NBP

Detail

Enriched 2026-08-14 20:47

Market cap
$216,262,704.35
Shares outstanding (class)
115,648,505
Shares outstanding (weighted)
115,648,505
SIC
Employees
30
Location
Description

NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data